Recent Patents on Inflammation & Allergy Drug Discovery
Title: Editorial
Volume: 6 Issue: 1
Author(s): Khurshid Zaman
Affiliation:
Export Options
About this article
Cite this article as:
Zaman Khurshid, Editorial, Recent Patents on Inflammation & Allergy Drug Discovery 2012; 6 (1) . https://dx.doi.org/10.2174/187221312798889293
DOI https://dx.doi.org/10.2174/187221312798889293 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
18
Related Articles
-
Src Tyrosine Kinase Inhibition Suppresses Lymphangiogenesis In Vitro and In Vivo
Current Cancer Drug Targets Applications of Muscle Electroporation Gene Therapy
Current Gene Therapy Structure-Activity Relationships of Flavonoids
Current Organic Chemistry Natural Compounds with Proteasome Inhibitory Activity for Cancer Prevention and Treatment
Current Protein & Peptide Science Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target
Current Cancer Therapy Reviews Pharmacokinetics of CNT-based Drug Delivery Systems
Current Drug Metabolism IL-24: Physiological and Supraphysiological Effects on Normal and Malignant Cells
Current Medicinal Chemistry The FRK / RAK-SHB Signaling Cascade: A Versatile Signal- Transduction Pathway that Regulates Cell Survival, Differentiation and Proliferation
Current Molecular Medicine Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
CNS & Neurological Disorders - Drug Targets Recent Patents of TGF-β Family and VEGF Associated with Ovarian Follicular Development in Mammals
Recent Patents on DNA & Gene Sequences Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells
Cardiovascular & Hematological Disorders-Drug Targets Genetic and Epigenetic Regulation of Phosphoinositide 3-kinase Isoforms
Current Pharmaceutical Design The Pathogenesis, Complications and Therapeutic Strategy for Hepatitis C Virus-associated Insulin Resistance in the Era of Anti-viral Treatment
Reviews on Recent Clinical Trials Multitarget Drugs of Plants Origin Acting on Alzheimer's Disease
Current Medicinal Chemistry Target Identification of Grape Seed Extract in Colorectal Cancer Using Drug Affinity Responsive Target Stability (DARTS) Technique: Role of Endoplasmic Reticulum Stress Response Proteins
Current Cancer Drug Targets IT-143, A Polymer Micelle Nanoparticle, Widens Therapeutic Window of Daunorubicin
Pharmaceutical Nanotechnology Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
Current Molecular Medicine HIF-1 Signaling in Drug Resistance to Chemotherapy
Current Medicinal Chemistry Roles of AFAP1-AS1 in Gynecology and Urogenital System
Current Pharmaceutical Design Induction of Apoptosis by Curcumin and Its Implications for Cancer Therapy
Current Cancer Drug Targets